Clinical Trial Update: Altshock-2 REGISTRY

View source ↗

Summary

Altshock-2 Registry is a recruiting registry trial sponsored by Niguarda Hospital investigating cardiogenic shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Snippet

Sponsor: Niguarda Hospital | Conditions: Cardiogenic Shock | Status: RECRUITING